Early use of continuous glucose monitoring in children and adolescents after total pancreatectomy with islet autotransplantation

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Children undergoing total pancreatectomy with islet autotransplantation (TPIAT) for chronic pancreatitis require intensive insulin therapy early after TPIAT with narrow glycemic targets, which can a present significant care burden. Outpatient use of continuous glucose monitoring (CGM) systems by children and caregivers early after TPIAT is inadequately studied. Methods: In this open-label study, we randomized 14 children and adolescents (mean age 15.4 years) after hospital discharge for TPIAT to Dexcom G6 CGM (n = 7) or standard care with a glucometer (n = 7) to assess acceptability and glycemic control with use of CGM versus usual care (glucometer). Participants in the control arm also wore a blinded CGM for 1 week. Result: Children randomized to real-time CGM had lower mean sensor glucose values compared with controls (p = 0.002), and high overall satisfaction with CGM. Conclusions: Our data indicate that CGM is a useful adjunct to diabetes management for children who have recently undergone TPIAT.

Original languageEnglish (US)
Pages (from-to)434-438
Number of pages5
JournalPediatric Diabetes
Volume22
Issue number3
DOIs
StatePublished - May 2021

Bibliographical note

Publisher Copyright:
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd

Keywords

  • TPIAT
  • continuous glucose monitoring
  • diabetes technology
  • islet transplantation

Fingerprint Dive into the research topics of 'Early use of continuous glucose monitoring in children and adolescents after total pancreatectomy with islet autotransplantation'. Together they form a unique fingerprint.

Cite this